Current developments in drug delivery with thermosensitive liposomes

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Thermosensitive liposomes (TSLs) are crucial for tumor-targeted chemotherapy.
• 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)-based TSLs enhance drug release near phase transition temperatures.
• Factors like lipid composition and serum components influence TSL temperature sensitivity.

Purpose of the Study:

• To review the development and recent advancements in innovative TSL formulations.
• To discuss the integration of TSLs with physical therapies like radiofrequency ablation (RFA) and high-intensity focused ultrasound (HIFU).
• To analyze factors affecting TSL design and performance.

Main Methods:

• Review of existing literature on TSLs in cancer therapy.
• Discussion of TSL formulations combined with physical stimuli (RFA, HIFU, MRI, AMF).
• Analysis of critical design parameters including lipid composition, surfactants, size, and serum interactions.

Main Results:

• DPPC-based TSLs show temperature-sensitive drug release.
• Innovative TSL formulations aim to improve thermal response and therapeutic efficacy.
• Combination therapies enhance TSL performance through external stimuli.

Conclusions:

• TSLs represent a promising strategy for enhanced tumor-targeted chemotherapy.
• Further research into TSL formulation and combination therapies can optimize cancer treatment.
• Understanding factors influencing TSL behavior is key to developing effective drug delivery systems.